Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Avantor
AVTR
$9.32B
| $11.3M | 0.01% |
536,065
-113,226
| -17% | -$2.58M |
|
1102
CALL
DraftKings
DKNG
$11.6B
| $11.3M | 0.01% |
585,000
-276,500
| -32% | -$4.6M |
|
1103
PUT
Teva Pharmaceuticals
TEVA
$40.8B
| $11.3M | 0.01% |
+1,278,900
| New | +$12.6M |
|
1104
Sociedad Química y Minera de Chile
SQM
$19.2B
| $11.3M | 0.01% |
139,566
-11,554
| -8% | -$995K |
|
1105
Marathon Digital Holdings
MARA
$4.32B
| $11.3M | 0.01% |
1,296,726
+1,165,498
| +888% | +$8.14M |
|
1106
Antero Resources
AR
$11.1B
| $11.3M | 0.01% |
489,587
+395,117
| +418% | +$10.4M |
|
1107
PUT
Helen of Troy
HELE
$644M
| $11.2M | 0.01% |
+118,100
| New | +$12.6M |
|
1108
Bio-Rad Laboratories Class A
BIO
$8.71B
| $11.2M | 0.01% |
23,406
-42,996
| -65% | -$20.1M |
|
1109
BellRing Brands
BRBR
$1.44B
| $11.2M | 0.01% |
327,958
+282,793
| +626% | +$8.35M |
|
|
DOCU
1110
PUT
DocuSign
DOCU
$10.5B
| $11.1M | 0.01% |
191,200
-74,000
| -28% | -$4.41M |
|
1111
BridgeBio Pharma
BBIO
$15.7B
| $11.1M | 0.01% |
670,879
-531,006
| -44% | -$6.19M |
|
1112
Sanofi
SNY
$103B
| $11.1M | 0.01% |
204,202
-70,941
| -26% | -$3.45M |
|
1113
ICU Medical
ICUI
$4.21B
| $11.1M | 0.01% |
67,232
+51,513
| +328% | +$8.86M |
|
1114
Karyopharm Therapeutics
KPTI
$43.5M
| $11.1M | 0.01% |
189,826
+120,045
| +172% | +$5.93M |
|
1115
CALL
Cencora
COR
$60.6B
| $11M | 0.01% |
69,000
-1,200
| -2% | -$190K |
|
1116
PUT
AT&T
T
$159B
| $11M | 0.01% |
573,400
-1,330,000
| -70% | -$25.4M |
|
1117
Alliant Energy
LNT
$18.3B
| $11M | 0.01% |
205,646
-87,354
| -30% | -$4.65M |
|
1118
PUT
PennyMac Financial
PFSI
$3.92B
| $10.9M | 0.01% |
+182,900
| New | +$11.3M |
|
1119
TotalEnergies
TTE
$195B
| $10.9M | 0.01% |
184,196
-72,618
| -28% | -$4.47M |
|
1120
CALL
RH
RH
$3.13B
| $10.9M | 0.01% |
44,600
-20,000
| -31% | -$5.81M |
|
1121
Otis Worldwide
OTIS
$27.4B
| $10.8M | 0.01% |
128,324
-326,826
| -72% | -$27M |
|
1122
Vail Resorts
MTN
$5.32B
| $10.8M | 0.01% |
46,239
-6,006
| -11% | -$1.45M |
|
1123
Marriott Vacations Worldwide
VAC
$3.35B
| $10.8M | 0.01% |
80,088
+2,044
| +3% | +$303K |
|
1124
Legend Biotech
LEGN
$3.59B
| $10.8M | ﹤0.01% |
223,538
-248,716
| -53% | -$12.2M |
|
1125
PUT
Caesars Entertainment
CZR
$6.06B
| $10.7M | ﹤0.01% |
220,100
+212,800
| +2,915% | +$10.4M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.